W
Wen-Yi Yang
Researcher at Shanghai Jiao Tong University
Publications - 109
Citations - 2084
Wen-Yi Yang is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Population & Blood pressure. The author has an hindex of 19, co-authored 98 publications receiving 1352 citations. Previous affiliations of Wen-Yi Yang include Stanford University & Katholieke Universiteit Leuven.
Papers
More filters
Journal ArticleDOI
Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes.
Wen-Yi Yang,Wen-Yi Yang,Jesus D. Melgarejo,Lutgarde Thijs,Zhen-Yu Zhang,Zhen-Yu Zhang,José Boggia,Fang-Fei Wei,Tine W. Hansen,Kei Asayama,Takayoshi Ohkubo,Jørgen Jeppesen,Eamon Dolan,Katarzyna Stolarz-Skrzypek,Sofia Malyutina,Edoardo Casiglia,Lars Lind,Jan Filipovský,Gladys E. Maestre,Gladys E. Maestre,Yan Li,Ji-Guang Wang,Yutaka Imai,Kalina Kawecka-Jaszcz,Edgardo Sandoya,Krzysztof Narkiewicz,Eoin O'Brien,Peter Verhamme,Jan A. Staessen,Jan A. Staessen +29 more
TL;DR: Higher 24-hour and nighttime blood pressure measurements were significantly associated with greater risks of death and a composite CV outcome, even after adjusting for other office-based or ambulatory blood pressureMeasurements, which were consistent for diastolic BP.
Journal ArticleDOI
The Cardiovascular Risk of White-Coat Hypertension
Stanley S. Franklin,Lutgarde Thijs,Kei Asayama,Yan Li,Tine W. Hansen,José Boggia,Lotte Jacobs,Zhenyu Zhang,Masahiro Kikuya,Kristina Björklund-Bodegård,Takayoshi Ohkubo,Wen-Yi Yang,Jørgen Jeppesen,Eamon Dolan,Tatiana Kuznetsova,Katarzyna Stolarz-Skrzypek,Valérie Tikhonoff,Sofia Malyutina,Edoardo Casiglia,Yuri Nikitin,Lars Lind,Edgardo Sandoya,Kalina Kawecka-Jaszcz,Jan Filipovský,Yutaka Imai,Ji-Guang Wang,Eoin O'Brien,Jan A. Staessen,Idaco Investigators +28 more
TL;DR: CVD risk in most persons with WCH is comparable to age- and risk-adjusted normotensive control subjects, and WCE size is related to aging, not to CVD risk.
Journal ArticleDOI
p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma
TL;DR: LincRNA-p21 acted as a tumor suppressor in HNSCC progression, which was attributed to direct binding to STAT3 and blocking of JAK2/STAT3 signaling, which suppressed STAT3-induced oncogenic potential.
Journal ArticleDOI
Additive Prognostic Value of Left Ventricular Systolic Dysfunction in a Population-Based Cohort
Tatiana Kuznetsova,Nicholas Cauwenberghs,Judita Knez,Wen-Yi Yang,Lieven Herbots,Jan D'hooge,Francois Haddad,Lutgarde Thijs,Jens-Uwe Voigt,Jan A. Staessen +9 more
TL;DR: Low GLS measured by 2-dimensional speckle tracking predicts future cardiovascular events independent of conventional risk factors, and represents a simple echocardiographic measure which might be used for assessing cardiovascular risk in a population-based cohort.
Journal ArticleDOI
Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension
Fadl Elmula M. Fadl Elmula,Yu Jin,Wen-Yi Yang,Lutgarde Thijs,Yi-Chao Lu,Anne Cecilie K Larstorp,Alexandre Persu,Marc Sapoval,Ján Rosa,Petr Widimský,Lotte Jacobs,Jean Renkin,Ondřej Petrák,Gilles Chatellier,Kazuyuki Shimada,Jiří Widimský,Kazuomi Kario,Michel Azizi,Sverre E. Kjeldsen,Jan A. Staessen +19 more
TL;DR: In selected rHT patients maintained on antihypertensive drugs, RDN with the SYMPLICITY systems does not significantly decrease BP but is safe, and future trials with next-generation catheters should aim at identifying responders in patients with evidence of sympathetic nervous overactivity.